Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Merzenich, Hiltrud; Bartkowiak, Detlef; Schmidberger, Heinz et al.
3D conformal radiotherapy is not associated with the long-term cardiac mortality in breast cancer patients: a retrospective cohort study in Germany (PASSOS-Heart Study)BREAST CANCER RESEARCH AND TREATMENT. Bd. 161. H. 1. 2017 S. 143-152
Schwab, R.; Battista, M. J. B.; Kuenzel, K. et al.
A CASE OF UTERINE RELAPSE IN A YOUNG WOMAN WITH A HISTORY OF ALL (ACUTE LYMPHOBLASTIC LEUKEMIA)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 27. 2017 S. 995-995
Thomssen, Christoph; Decker, Thomas; Fehm, Tanja et al.
A PHASE II STUDY OF METRONOMIC DAILY ORAL VINORELBINE AS FIRST-LINE CHEMOTHERAPY IN ADVANCED/METASTATIC HORMONE RECEPTOR POSITIVE (HR plus )/HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE (HER2-) BREAST CANCER RESISTANT TO ENDOCRINE THERAPY: VINOMETROBREAST. Bd. 36. 2017 S. S51-S51
Harbeck, Nadia; Saupe, Steffen; Jaeger, Elke et al.
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN studyBREAST CANCER RESEARCH AND TREATMENT. Bd. 161. H. 1. 2017 S. 63-72
Loibl, Sibylle; Barinoff, Jana; Seiler, Sabine et al.
A randomized, open-label, multicentre, phase IV study evaluating palbociclib plus endocrine treatment versus a chemotherapy based treatment strategy in patients with hormone receptor positive/HER2-negative metastatic breast cancer in a real world settingJOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017
Heimes, A. S.; Schmidt, M.; Jaekel, J. et al.
A RETROSPECTIVE ANALYSIS OF IMMUNOHISTOCHEMICAL DETERMINED IRF4 (INTERFERON REGULATING FACTOR 4) EXPRESSION IN A CONSECUTIVE COHORT OF 114 OVARIAN CANCER PATIENTSINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 27. 2017 S. 1520-1520
Thill, Marc; Liedtke, Cornelia; Solomayer, Erich-Franz et al.
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2017BREAST CARE. Bd. 12. H. 3. 2017 S. 184-191
Makris, Georgios-Marios; Marinelis, Alexandros; Battista, Marco-Johannes et al.
An ovarian mass after breast cancer: Metachronous carcinoma or metastasis? A case reportINTERNATIONAL JOURNAL OF SURGERY CASE REPORTS. Bd. 31. 2017 S. 106-108
Fasching, Peter A.; Grischke, Eva -Maria; Schuetz, Florian et al.
Analysis of everolimus starting dose as prognostic marker in HR plus mBC patients treated with everolimus (EVE) plus exemestane (EXE): Results of the 3rd interim analysis of the non-interventional trial BRAWO.JOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017
Frees, Sebastian; Kamal, Mohammed; Nestler, Sebastian et al.
ARE THE CURRENT FOLLOW-UP GUIDELINES AFTER TREATMENT FOR ORGAN CONFINED RENAL CANCER SUFFICIENT?JOURNAL OF UROLOGY. Bd. 197. H. 4. 2017 S. E914-E914